150 related articles for article (PubMed ID: 11452710)
1. Single-dose pharmacokinetics of bupropion in adolescents: effects of smoking status and gender.
Stewart JJ; Berkel HJ; Parish RC; Simar MR; Syed A; Bocchini JA; Wilson JT; Manno JE
J Clin Pharmacol; 2001 Jul; 41(7):770-8. PubMed ID: 11452710
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of bupropion and its metabolites in cigarette smokers versus nonsmokers.
Hsyu PH; Singh A; Giargiari TD; Dunn JA; Ascher JA; Johnston JA
J Clin Pharmacol; 1997 Aug; 37(8):737-43. PubMed ID: 9378846
[TBL] [Abstract][Full Text] [Related]
3. Bupropion for major depressive disorder: Pharmacokinetic and formulation considerations.
Jefferson JW; Pradko JF; Muir KT
Clin Ther; 2005 Nov; 27(11):1685-95. PubMed ID: 16368442
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of Bupropion and Its Pharmacologically Active Metabolites in Pregnancy.
Fokina VM; Xu M; Rytting E; Abdel-Rahman SZ; West H; Oncken C; Clark SM; Ahmed MS; Hankins GD; Nanovskaya TN
Drug Metab Dispos; 2016 Nov; 44(11):1832-1838. PubMed ID: 27528039
[TBL] [Abstract][Full Text] [Related]
5. Cytochrome P450 2B6 activity as measured by bupropion hydroxylation: effect of induction by rifampin and ethnicity.
Loboz KK; Gross AS; Williams KM; Liauw WS; Day RO; Blievernicht JK; Zanger UM; McLachlan AJ
Clin Pharmacol Ther; 2006 Jul; 80(1):75-84. PubMed ID: 16815319
[TBL] [Abstract][Full Text] [Related]
6. Effects of menthol on the pharmacokinetics of bupropion among Black smokers.
Okuyemi KS; Faseru B; Reed GA; Cox LS; Bronars CA; Opole I; Whembolua GL; Mayo MS; Ahluwalia JS; Benowitz NL
Nicotine Tob Res; 2012 Jun; 14(6):688-93. PubMed ID: 22318754
[TBL] [Abstract][Full Text] [Related]
7. Steady-state pharmacokinetics of bupropion SR in juvenile patients.
Daviss WB; Perel JM; Rudolph GR; Axelson DA; Gilchrist R; Nuss S; Birmaher B; Brent DA
J Am Acad Child Adolesc Psychiatry; 2005 Apr; 44(4):349-57. PubMed ID: 15782082
[TBL] [Abstract][Full Text] [Related]
8. Development, validation and application of a comprehensive stereoselective LC/MS-MS assay for bupropion and oxidative, reductive, and glucuronide metabolites in human urine.
Teitelbaum AM; Flaker AM; Kharasch ED
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Aug; 1027():239-53. PubMed ID: 27318149
[TBL] [Abstract][Full Text] [Related]
9. Stereoselective bupropion hydroxylation as an in vivo phenotypic probe for cytochrome P4502B6 (CYP2B6) activity.
Kharasch ED; Mitchell D; Coles R
J Clin Pharmacol; 2008 Apr; 48(4):464-74. PubMed ID: 18287571
[TBL] [Abstract][Full Text] [Related]
10. Lack of effect of cimetidine on the pharmacokinetics of sustained-release bupropion.
Kustra R; Corrigan B; Dunn J; Duncan B; Hsyu PH
J Clin Pharmacol; 1999 Nov; 39(11):1184-8. PubMed ID: 10579150
[TBL] [Abstract][Full Text] [Related]
11. Steady-state clinical pharmacokinetics of bupropion extended-release in youths.
Daviss WB; Perel JM; Birmaher B; Rudolph GR; Melhem I; Axelson DA; Brent DA
J Am Acad Child Adolesc Psychiatry; 2006 Dec; 45(12):1503-9. PubMed ID: 17135996
[TBL] [Abstract][Full Text] [Related]
12. Chiral Plasma Pharmacokinetics and Urinary Excretion of Bupropion and Metabolites in Healthy Volunteers.
Masters AR; Gufford BT; Lu JB; Metzger IF; Jones DR; Desta Z
J Pharmacol Exp Ther; 2016 Aug; 358(2):230-8. PubMed ID: 27255113
[TBL] [Abstract][Full Text] [Related]
13. Gene variants in CYP2C19 are associated with altered in vivo bupropion pharmacokinetics but not bupropion-assisted smoking cessation outcomes.
Zhu AZ; Zhou Q; Cox LS; Ahluwalia JS; Benowitz NL; Tyndale RF
Drug Metab Dispos; 2014 Nov; 42(11):1971-7. PubMed ID: 25187485
[TBL] [Abstract][Full Text] [Related]
14. Serum concentrations of hydroxybupropion for dose optimization of depressed patients treated with bupropion.
Laib AK; Brünen S; Pfeifer P; Vincent P; Hiemke C
Ther Drug Monit; 2014 Aug; 36(4):473-9. PubMed ID: 24452068
[TBL] [Abstract][Full Text] [Related]
15. Effects of woohwangcheongsimwon suspension on the pharmacokinetics of bupropion and its active metabolite, 4-hydroxybupropion, in healthy subjects.
Kim H; Bae SK; Park SJ; Shim EJ; Kim HS; Shon JH; Liu KH; Shin JG
Br J Clin Pharmacol; 2010 Jul; 70(1):126-31. PubMed ID: 20642555
[TBL] [Abstract][Full Text] [Related]
16. Acute antidepressant response and plasma levels of bupropion and metabolites in a pediatric-aged sample: an exploratory study.
Daviss WB; Perel JM; Brent DA; Axelson DA; Rudolph GR; Gilchrist R; Nuss S; Birmaher B
Ther Drug Monit; 2006 Apr; 28(2):190-8. PubMed ID: 16628130
[TBL] [Abstract][Full Text] [Related]
17. Population Pharmacokinetics, Safety and Tolerability of Extended-Release Bupropion and Its Three Metabolites in Chinese Healthy Volunteers.
Zhang F; Li Y; Hu J; Zhong J; Li H
Eur J Drug Metab Pharmacokinet; 2019 Jun; 44(3):339-352. PubMed ID: 30520001
[TBL] [Abstract][Full Text] [Related]
18. Lopinavir/ritonavir reduces bupropion plasma concentrations in healthy subjects.
Hogeland GW; Swindells S; McNabb JC; Kashuba AD; Yee GC; Lindley CM
Clin Pharmacol Ther; 2007 Jan; 81(1):69-75. PubMed ID: 17186001
[TBL] [Abstract][Full Text] [Related]
19. Development and validation of a high-throughput stereoselective LC-MS/MS assay for bupropion, hydroxybupropion, erythrohydrobupropion, and threohydrobupropion in human plasma.
Teitelbaum AM; Flaker AM; Kharasch ED
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Apr; 1017-1018():101-113. PubMed ID: 26963497
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of single- and multiple-dose bupropion in elderly patients with depression.
Sweet RA; Pollock BG; Kirshner M; Wright B; Altieri LP; DeVane CL
J Clin Pharmacol; 1995 Sep; 35(9):876-84. PubMed ID: 8786247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
